Core Viewpoint - The legal opinion letter issued by Zhejiang Tiance Law Firm confirms that Zhejiang Gongdong Medical Devices Co., Ltd.'s differentiated equity distribution plan for the 2024 profit distribution complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][4][7]. Group 1: Differentiated Equity Distribution - The company plans to repurchase shares using self-owned funds through centralized bidding, with the repurchased shares intended for employee stock ownership plans or equity incentives [4]. - As of the date of the legal opinion, the number of shares in the repurchase account is 292,080, accounting for 0.19% of the total share capital of 157,578,415 shares [4]. - The repurchased shares will not participate in the 2024 profit distribution, leading to a need for special handling of the differentiated equity distribution [4][5]. Group 2: Profit Distribution and Repurchase Amount - The company distributed a total cash dividend of 109,813,154.50 yuan for the first half of 2024, with the total cash dividend and repurchase amount combined reaching 145,810,244.10 yuan, which is 84.95% of the net profit attributable to shareholders [5]. - The repurchase amount for the year is 35,997,089.60 yuan, which is considered in the cash dividend calculation [5]. Group 3: Calculation Basis for Differentiated Equity Distribution - The total share capital as of the date of the legal opinion is 157,578,415 shares, with 157,286,335 shares participating in the distribution [6]. - The reference price for ex-rights and ex-dividends is calculated based on the previous closing price and cash dividends, resulting in an actual distribution reference price of 19.1714 yuan per share [6][7]. - The impact of the differentiated equity distribution on the reference price is minimal, with an absolute value of less than 1% [7]. Group 4: Conclusion - The legal opinion concludes that the differentiated equity distribution plan adheres to the Company Law, Securities Law, and relevant regulatory guidelines, ensuring the protection of the interests of the company and its shareholders [7].

Core Viewpoint - The report outlines the differentiated dividend distribution plan of Youlide Technology (China) Co., Ltd., confirming compliance with relevant laws and regulations, and indicating that the plan does not harm the interests of the company and its shareholders [5]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is due to the company's decision to adjust the total cash dividend amount for the 2024 fiscal year, as announced on May 17, 2025 [1]. - The company has completed the registration of an additional 499,051 shares, increasing the total share capital from 111,281,997 shares to 111,781,048 shares [1]. Group 2: Dividend Distribution Plan - The company plans to distribute a cash dividend of 10.00 yuan (including tax) for every 10 shares held, resulting in a total cash dividend distribution of 111,036,148 yuan (including tax) [2]. - The actual number of shares participating in the profit distribution is 111,036,148 shares after excluding 744,900 shares held in the repurchase account [2]. Group 3: Calculation Basis for Dividend Distribution - The reference price for ex-dividend trading is calculated using the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [3]. - With a closing price of 34.20 yuan on May 21, 2025, the calculated cash dividend per share is approximately 1.0 yuan, resulting in an ex-dividend reference price of 33.20 yuan per share [3][4]. - The impact of the differentiated dividend on the ex-dividend reference price is negligible, remaining below 1% [4]. Group 4: Sponsor Institution's Review Opinion - The sponsor institution, Changcheng Securities, confirms that the differentiated dividend distribution complies with the Company Law, Securities Law, and other relevant regulations, ensuring no harm to the interests of the company and its shareholders [5].

内蒙古建中律师事务所 关于金宇生物技术股份有限公司差异化 权益分派特殊除权除息事项之法律意见书 致：金宇生物技术股份有限公司 本所接受金宇生物技术股份有限公司（以下简称"公司"）的委托，根据《中华 人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以 下简称"《证券法》"）、《上市公司股份回购规则》、《关上海证券交易所上市公 司自律监管指引第7号——回购股份》等法律、法规、规章和其他规范性文件以及 《公司章程》的规定，就公司2024年度利润分配所涉及的差异化权益分派特殊除权 除息（以下简称"本次差异化权益分派"）相关事项出具本法律意见书。 为出具本法律意见书，本所律师谨作如下声明： 本所及本所律师审查了公司提供的本次差异化权益分派的相关文件，就有关事 项向公司进行了必要的询问。本所律师依据本法律意见书出具日前已经发生或存在 的事实并基于对现行法律、法规和规范性文件的理解发表法律意见。 本法律意见书仅就本次差异化权益分派所涉及到的法律问题发表法律意见，并 不对有关会计、审计等专业事项和报告发表意见。本法律意见书中对有关审计报告 中某些数据和结论的引述，并不意味着本所对这些数据、结论的真实性 ...

Core Points - The company has announced a cash dividend of 0.236 CNY per share for its shareholders [1][6] - The dividend distribution plan was approved at the annual general meeting held on May 19, 2025 [1][2] - The record date for the dividend is June 26, 2025, with the ex-dividend date and payment date both set for June 27, 2025 [2][4] Dividend Distribution Details - The company will distribute a cash dividend of 2.36 CNY for every 10 shares held, with no stock dividends or capital reserve transfers [1][2] - The total share capital of the company is 309,441,175 shares, and the cash dividend amount is approximately 71,433,522.88 CNY (including tax) [2][3] - The calculation for the ex-dividend reference price will be based on the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio), with the circulating shares ratio being 0 for this distribution [2][3] Tax Implications - For individual shareholders holding shares for over one year, the dividend income is exempt from personal income tax [6][7] - For shares held for less than one year, the tax will be calculated upon the sale of the shares, with a tax rate of 20% for holdings of one month or less, and 10% for holdings between one month and one year [6][7] - For qualified foreign institutional investors (QFII), the net dividend after tax will be 0.2124 CNY per share [7]

Core Viewpoint - The 2024 Annual General Meeting of Kunshan Longteng Optoelectronics Co., Ltd. aims to ensure the rights of all shareholders and maintain the order and efficiency of the meeting, adhering to relevant laws and regulations [1][2][3]. Meeting Procedures - Shareholders or their proxies must arrive 30 minutes before the meeting to complete registration and present necessary identification documents [2][3]. - The meeting will follow a predetermined agenda for reviewing and voting on proposals [2][3]. - Shareholders have the right to speak, consult, and vote during the meeting, but must register in advance to speak [2][3][4]. - Voting will be conducted through a combination of on-site and online methods, with results announced after the meeting [2][3][4]. Financial Performance - In 2024, the company experienced a 9.77% decrease in total revenue compared to the previous year, while the net profit attributable to shareholders improved by 31.64% [6][20]. - The company’s financial structure remains robust, with a debt-to-asset ratio of 34.84%, which is lower than the industry average [6][20]. Board of Directors' Work - The Board of Directors held three meetings in 2024, reviewing 29 proposals related to financial management and corporate governance [6][8]. - The Board aims to enhance shareholder value and ensure compliance with legal and regulatory requirements [8][9]. Supervisory Board's Role - The Supervisory Board conducted three meetings in 2024, focusing on the legality and compliance of the company's operations and financial status [13][14]. - The Supervisory Board confirmed that the company adhered to relevant laws and regulations, ensuring the protection of shareholder interests [14][15]. Future Plans - The company plans to enhance its governance structure and improve information disclosure management to foster better investor relations [9][12]. - The 2025 work plan includes continuous improvement of governance practices and compliance with legal standards [9][12]. Proposals for Shareholder Approval - The company proposed not to distribute profits for 2024, opting to reinvest retained earnings into project development and market expansion [23]. - A proposal to apply for a comprehensive credit limit of up to 73.3 billion yuan from banks was also presented [25]. - The company intends to continue its partnership with the auditing firm Gongzheng Tianye for the 2025 fiscal year [24].

申万宏源证券承销保荐有限责任公司 股东回报规划》的规定，对亨通光电 2024 年度利润分配所涉及的差异化分红（以 下简称"本次差异化分红"）相关事项进行了审慎核查，核查情况如下： 一、本次差异化分红的原因 监事会第二十四次会议，审议通过了关于《以集中竞价交易方式回购公司股份方 案》的议案，拟以自有资金回购公司股份。截至 2023 年 12 月 20 日，亨通光电 实际回购公司股份 8,436,800 股，支付的总金额 9,999.03 万元（不含交易费用）， 回购方案实际执行情况与原披露的回购方案不存在差异，本次回购股份方案已实 施完毕。 事会第二十八次会议，审议通过了关于《以集中竞价交易方式回购公司股份方案》 的议案，拟以自有资金回购公司股份。截至 2025 年 1 月 14 日，亨通光电实际回 购公司股份 14,168,695 股，支付的总金额 15,561.22 万元（不含交易费用），回购 方案实际执行情况与原披露的回购方案不存在差异，本次回购股份方案已实施完 毕。 关于江苏亨通光电股份有限公司 差异化分红事项的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"保荐机构"）作为江苏亨 通光电股份有限 ...

Core Viewpoint - Guizhou Sanli Pharmaceutical Co., Ltd. is implementing a differentiated dividend distribution plan due to the repurchase of shares and the cancellation of certain restricted stocks, ensuring compliance with relevant laws and regulations [2][7]. Group 1: Reasons for Differentiated Dividend - The company plans to repurchase and cancel 60,000 restricted stocks from one employee who no longer qualifies for the incentive program due to resignation [3]. - Additionally, 732,000 restricted stocks from seven employees will be repurchased and canceled as the company's performance did not meet the conditions for the third release period of the 2021 incentive plan [3]. Group 2: Dividend Distribution Plan - The total share capital of the company is 409,802,216 shares, and the company will distribute a cash dividend of 3.40 yuan (including tax) for every 10 shares to eligible shareholders, adjusting the total distribution amount accordingly due to the repurchased shares [5][6]. - The total cash dividend to be distributed amounts to 137,638,805.44 yuan (including tax) [5]. Group 3: Calculation Basis for Differentiated Dividend - As of May 29, 2024, the closing price of the company's shares was 12.02 yuan per share, with a total of 4,982,200 shares in the repurchase account [6]. - The reference price for ex-dividend is calculated to be approximately 11.68 yuan per share, with a minimal impact of 0.0351% on the reference price due to the differentiated dividend distribution [6][7]. Group 4: Legal Compliance and Conclusion - The legal opinion confirms that the differentiated dividend distribution complies with the Company Law, Securities Law, and relevant regulations, and does not harm the interests of the company or its shareholders [7].

Core Viewpoint - The legal opinion letter from Yuanwen (Shanghai) Law Firm confirms the legality and compliance of Suzhou Mingzhi Technology Co., Ltd.'s differentiated dividend distribution for the fiscal year 2024, ensuring it aligns with relevant laws and regulations [1][8]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is necessitated by the company's repurchased shares, which do not participate in profit distribution as per the relevant laws and regulations [4][5]. - The company plans to distribute a cash dividend of 4.50 yuan per 10 shares (including tax), excluding the 534,750 shares held in the repurchase account from this distribution [5][6]. - The total number of shares eligible for profit distribution is calculated to be 123,421,322 shares after excluding the repurchased shares from the total share capital of 123,956,072 shares [6][7]. Group 2: Legal Compliance and Verification - The law firm has conducted thorough verification of the legal compliance of the differentiated dividend distribution, ensuring no false records or misleading statements exist [2][3]. - The legal opinion letter serves as a necessary legal document for the company's differentiated dividend distribution and is subject to legal responsibility by the law firm [2][3]. - The law firm emphasizes that it only provides opinions on legal matters related to the differentiated dividend distribution and does not assess accounting or financial aspects [3][4].

Core Points - The company announced a cash dividend of 0.015 CNY per share for A shares [1][4] - The dividend distribution plan was approved at the annual general meeting on May 21, 2025 [1][3] - The record date for the dividend is June 26, 2025, with the ex-dividend date also on June 27, 2025 [1][3] Dividend Distribution Details - The total share capital for the dividend distribution is 761,335,236 shares, with 26,062,913 shares in the repurchase account excluded from the distribution [2][3] - The actual number of shares eligible for dividend distribution is 735,272,323 shares, resulting in an effective cash dividend of approximately 0.0145 CNY per share [3] - The company will not issue new shares or increase capital through reserves in this distribution [2][3] Taxation and Payment Procedures - For individual shareholders holding shares for over one year, the cash dividend is exempt from personal income tax, while those holding for less than one year will have tax withheld upon sale [4][5] - The actual cash dividend after tax for limited shares is 0.0135 CNY per share [5] - Qualified foreign institutional investors (QFII) will have a 10% withholding tax applied, with the possibility of tax refund applications [5][6] Payment Method - Cash dividends for unrestricted shares will be distributed through the China Securities Depository and Clearing Corporation [4][6] - Shareholders who have not completed designated transactions will have their dividends held by the clearing company until the transaction is completed [4]

佘宗明 | 文 刘强东预告的"京东进军酒旅"，来了。6月18日，京东面向全体酒店经营者发布公开信，称希望通过新通路的方式为酒店行业提供供应链服务。 京东还表示，酒店商家如果参与"京东酒店PLUS会员计划"，可享受最高三年0佣金。 说起来，京东涉足酒旅业务已有多年：2011年，上线了机票预订服务；2014年，推出了"京东旅行"频道，还收购了"今夜酒店特价"预订平台；2015年，以3.5 亿美元领投途牛；2018年，举办了"酒店战略发布会"；2020年，与携程合作……但整体上，京东酒旅业务的优先级不算太高，激起的声量十分有限。 这次京东又以搅局者姿态高调杀入酒旅市场，显然不是试水那么简单：无论是被传言以3倍薪资从友商处挖人，还是打出"零捆绑，透明价"+价格补贴的策 略，抑或是对酒店大幅度减免佣金、免前置坑位费，都表明京东此举已超越单一酒旅业务线的盈利考量，变成生态协同棋盘上的战略性落子。 长期以来，酒旅都属于高毛利业务：今年一季度，携程酒旅业务毛利率达到80.32%；在2022年第二季度调整财报披露方式前，财报也显示酒旅是美团利润 贡献最多的业务，当年一季度美团到店酒旅业务收入虽然只有餐饮外卖的约1/3，但前者利 ...